New infusion tested to tame gluten reaction in celiac patients
NCT ID NCT05660109
Summary
This study tested a new medicine called TPM502, given by infusion, to see if it could help adults with celiac disease become more tolerant to gluten. Researchers wanted to know if the treatment was safe and if it changed the body's immune response to gluten. Participants received two infusions and underwent controlled gluten challenges to measure the effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRST Oy
Turku, FI-20520, Finland
-
Centre for Human Drug Research
Leiden, 2333 ZA, Netherlands
-
Charite' Hospital
Berlin, 12200, Germany
-
Clinical Trial Consultants, Uppsala University
Uppsala, 752 37, Sweden
-
Oslo University Hospital HF - Rikshospitalet
Oslo, 0372, Norway
-
Royal Adelaide Hospital
Adelaide, 5000, Australia
-
University Hospital of North-Norway
Tromsø, 9038, Norway
-
Wesley Research Institute
Brisbane, 4066, Australia
Conditions
Explore the condition pages connected to this study.